197 related articles for article (PubMed ID: 28471454)
21. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
[TBL] [Abstract][Full Text] [Related]
22. Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn.
Shen X; Xing S; Zhang L; Wang F; Ou H; Shan Y; Xiao H; Xiong G; Wang X; Zhao Q; Cong Y; Yu Z
Biochem Biophys Res Commun; 2018 Jul; 502(1):110-115. PubMed ID: 29787755
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
24. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
25. The role of TLR8 signaling in acute myeloid leukemia differentiation.
Ignatz-Hoover JJ; Wang H; Moreton SA; Chakrabarti A; Agarwal MK; Sun K; Gupta K; Wald DN
Leukemia; 2015 Apr; 29(4):918-926. PubMed ID: 25283842
[TBL] [Abstract][Full Text] [Related]
26. Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes.
Qi XF; Kim DH; Yoon YS; Jin D; Huang XZ; Li JH; Deung YK; Lee KJ
J Cell Physiol; 2009 Sep; 220(3):690-7. PubMed ID: 19472212
[TBL] [Abstract][Full Text] [Related]
27. Z-Ligustilide Selectively Targets AML by Restoring Nuclear Receptors Nur77 and NOR-1-mediated Apoptosis and Differentiation.
Wang C; Liu G; Dou G; Yang Y; Chen L; Ma H; Jiang Z; Ma H; Li C; Li L; Jiang M; Lu Q; Li P; Qi H
Phytomedicine; 2021 Feb; 82():153448. PubMed ID: 33421904
[TBL] [Abstract][Full Text] [Related]
28. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
29. Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation.
Nitulescu II; Meyer SC; Wen QJ; Crispino JD; Lemieux ME; Levine RL; Pelish HE; Shair MD
EBioMedicine; 2017 Dec; 26():112-125. PubMed ID: 29239838
[TBL] [Abstract][Full Text] [Related]
30. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
Cornet-Masana JM; Moreno-Martínez D; Lara-Castillo MC; Nomdedeu M; Etxabe A; Tesi N; Pratcorona M; Esteve J; Risueño RM
Oncotarget; 2016 Apr; 7(17):23239-50. PubMed ID: 26992240
[TBL] [Abstract][Full Text] [Related]
31. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
[TBL] [Abstract][Full Text] [Related]
32. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
Lo RK; Wise H; Wong YH
Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors.
Yadav M; Singh AK; Kumar H; Rao G; Chakravarti B; Gurjar A; Dogra S; Kushwaha S; Vishwakarma AL; Yadav PN; Datta D; Tripathi AK; Chattopadhyay N; Trivedi AK; Sanyal S
Biochim Biophys Acta; 2016 Oct; 1860(10):2178-90. PubMed ID: 27180173
[TBL] [Abstract][Full Text] [Related]
34. LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.
Dai C; Zhang C; Sun X; Pan Q; Peng J; Shen J; Ma X
Int J Biochem Cell Biol; 2016 Jul; 76():107-14. PubMed ID: 27102414
[TBL] [Abstract][Full Text] [Related]
35. SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains.
Rzymski T; Mikula M; Żyłkiewicz E; Dreas A; Wiklik K; Gołas A; Wójcik K; Masiejczyk M; Wróbel A; Dolata I; Kitlińska A; Statkiewicz M; Kuklinska U; Goryca K; Sapała Ł; Grochowska A; Cabaj A; Szajewska-Skuta M; Gabor-Worwa E; Kucwaj K; Białas A; Radzimierski A; Combik M; Woyciechowski J; Mikulski M; Windak R; Ostrowski J; Brzózka K
Oncotarget; 2017 May; 8(20):33779-33795. PubMed ID: 28422713
[TBL] [Abstract][Full Text] [Related]
36. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
38. VEGFC Antibody Therapy Drives Differentiation of AML.
Kampen KR; Scherpen FJG; Mahmud H; Ter Elst A; Mulder AB; Guryev V; Verhagen HJMP; De Keersmaecker K; Smit L; Kornblau SM; De Bont ESJM
Cancer Res; 2018 Oct; 78(20):5940-5948. PubMed ID: 30185550
[TBL] [Abstract][Full Text] [Related]
39. Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells.
Chen Y; Hui H; Yang H; Zhao K; Qin Y; Gu C; Wang X; Lu N; Guo Q
Blood; 2013 May; 121(18):3682-91. PubMed ID: 23487022
[TBL] [Abstract][Full Text] [Related]
40. PLSCR1/IP3R1/Ca
Li H; Xu J; Zhou Y; Liu X; Shen LE; Zhu YU; Li Z; Wang X; Guo Q; Hui H
Cell Death Dis; 2017 May; 8(5):e2768. PubMed ID: 28492556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
